Peter A. Scott
update our we sheet Today Starting with Shoreline Technology the with guidance a results was a of result share per review delivered as the which of and, on cash results, Tom. growth, quarter I start transaction portfolio in line for finally, NOI an balance our as update will our and to the Thanks, for adjusted of the the expectation. our our quarter same-store FFO X.X% third year. reported with remainder and of $X.XX provide year-over-year
more provide me around Let details major our segments.
NOI X.X% cash by same-store office, driven over the in-place grew medical For prior lease escalators. year, primarily
medical for buildings. see office We to continue tenant demand strong
the driven our at Medical high the Dallas level. we for prior-year which our over and a positive the portfolio, in strong our where grew and performance to period. in is renewals cash Our hospital X%. segment, property expansion small over share is on is HCP had City performing year which success campus, This structure mark-to-market allows retention X.X% at primarily by the XX% other of NOI rate hospital, result Same-store our a of rent was our lease
integrated, campus a Medical in by in hospital is an over medical operated Dallas office medical square foot reminder, campuses entire includes hospital square our is fully The As campus XXX,XXX the one space. of feet portfolio. on-campus and the HCA trophy within XXX-bed This a X truly medical country. million of City office leading
driven NOI rents. same-store rent on over by cash contractual positive and grew mark-to-market For third the escalators quarter science, prior X.X% life year,
and development which progress have same-store incredible prior cash sciences, development our Excluding to life the mark-to-market From impact of approximately the X.X%. de-risked science on discussed have significantly a active leasing Rigel growth perspective lease, continue the of calls, life NOI would we been we within make have pipeline.
entire developing treatments Global the of for IV with for biotech signed a The feet Phase blood-based on quarter, focused disorders. rapidly traded a XXX,XXX GBT publicly the During at growing company Cove. square is we Blood Therapeutics lease
pre-lease. We are square Sierra at MyoKardia square feet Francisco are at XXX,XXX now in-process the and The we to a company, our of entire that Shore South we and I feet pre-leased development Cove. across project, development announce other remaining executed of San high with pleased the Point, At major pharma now have entire quality Phase The leases XXX,XXX have XXX%
the Our science leasing the strength market. progress well Francisco San are expectations of see we is from ahead Shore momentum we and The at South life in benefiting and
have triple-net housing SHOP Brookdale. X.X% This was On same-store a our negative with cash in account finally, NOI our been the third growth cash in And Same-store quarter. senior announced line our X.X%. adjustment approximately expectations rent normalized in the basis, and was cash takes For X.X%. housing with same-store portfolio, NOI portfolio. grew senior would into triple-net quarter year-over-year for previously NOI the
performance As and grew an portfolio continues or momentarily. plan performance positive of additional the we to provide the will portfolio color the a X.X% our between and which senior housing our disparity core discussed quarter the during quarter, last Scott XX%. there operator update transitions transition to on which declined significant on we our sell be a in assets
across to the that the significantly proceeds we Initially, pay profile sale to $X interest blended $XXX bond we our Shoreline planned balance line rate the of debt. will X.X%. credit the of million proceeds $XXX balance intend from sheet The use transaction. repay million balance have result The our net of loan improved approximately reduce billion rate as the of credit. be average million we and is and sheet, net to term the an now to of of $XXX or we at used Turning a debt
adjusted will of mid-X our times X.X reported the be reduced repayment debt or net third the we of With range, a the down full-term quarter. EBITDA at times end from to the debt, nearly the to
expectation it during into stated, and our development XXXX we and of to portion redevelopment redeploy As will pipelines. Tom fund a this accretive capacity sheet that our acquisitions strategic balance select is
basis settle crystallized part a loss net incorporating run the of XXXX. rate adjusted capital. in late utilize range the Importantly, QCP will we that sale to expect high-X on our note, EBITDA spin-off reinvestment the this this remaining carry-forward debt we in Of as to of after times tax
Turning our dividend of cash board $X.XX quarterly declared XX, October dividend, of to a directors on per the share.
triple-net per share guidance life the science range We earning significant X.XX% also upside life science with expect By our which our the approximately in aggregate near-term. trending covered payout mid-XX% opportunity time, our escalators maintaining year segment: our dividend the future opportunity transition and of Over senior low-end guidance high-end the our range a the Finishing towards in now $X.XX pipeline, X.XX%. the SHOP and $X.XX as FFO ratio are office the range lease we to the are other expect the range. housing our segment, guidance, adjusted trending to trending of in in-place medical in remain our development our with are towards our fully and positive decline currently SPP towards middle; reaffirming X.XX%, benefit is full the portfolio. of to we of and to mark-to-market from and average from ranges;
details call With turn Scott. our like on capital found our with that, to supplemental. XX would of can pricing of I the related to Additional recycling, along our guidance, be and page timing to over